id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2185-0006,FDA,FDA-2022-E-2185,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-01-18T05:00:00Z,2024,1,2024-01-18T05:00:00Z,,2025-01-13T19:51:37Z,,0,0,09000064863a977a
FDA-2022-E-2185-0005,FDA,FDA-2022-E-2185,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T20:55:22Z,,0,0,090000648638a3c3